Home / Community / News / News

News

03/06/2018 - 5:29pm

Speech disorders (dysarthria) in CDM and childhood-onset DM1 have long been recognized and surveillance by speech and language therapists is an important aspect of patient care. Facial weakness and myotonia, and involvement of oral cavity, palatopharyngeal and respiratory muscles, are known to contribute to speech impairment.

02/06/2018 - 9:52am

After a new review of the literature, the question of comorbidity of childhood DM1 and autism spectrum remains an open one.

01/07/2018 - 3:51pm

Discovery of the holy grail for DM therapy development-- drug registration endpoints -- lies in the dogged pursuit and sharing of natural history data.

01/07/2018 - 3:43pm

A new study examines the role of the GSK3β—cyclin D3—CUGBP1 pathway in the pathogenesis of DM1 and its potential as a therapeutic target.

01/07/2018 - 3:29pm

Development of a mini gene tool facilitates the identification of candidate therapeutics targeted at dissociating MBNL from expanded CUG repeats.

Partners

© Myotonic Dystrophy Foundation. All rights reserved.